Company

Celltrion Inc. Enters CDMO Arena Amid Shifts in Global Biosecurity Landscape

CompanyDeals

Gilead Sciences Partners with AI Firm Genesis Therapeutics to Develop Novel Small-Molecule Therapies

CompanyDeals

Carisma Therapeutics and Moderna Expand Partnership to Target Autoimmune Diseases with CAR-M Therapies

CompanyDeals

Itcure Expands Gene Editing Reach with Collaborations in China’s Biotech Sector

CompanyDrug

Qilu Pharmaceutical’s Iruplinalkib Shows Promising Results in Phase II Study for ALK+ NSCLC

CompanyDeals

ImmuneOnco Receives Second Payment from Instil Bio, Highlighting Ongoing Licensing Deal

CompanyDrug

Nuance Pharma Completes Enrollment for Phase III COPD Trial of Ohtuvayre in China

CompanyDrug

Innovent Biologics Presents Promising Phase I Data for IBI363 in Advanced NSCLC at WCLC

CompanyDrug

Betta Pharmaceuticals’ MCLA129 for Advanced Solid Tumors Accepted for Review by China’s NMPA

CompanyDrug

Duality Biologics Initiates Global Clinical Trial for DB-1419 in Advanced Solid Tumors

CompanyMedical Device

Medtronic Secures China Market Approval for Pulsed Electric Field Atrial Fibrillation Treatment Devices

CompanyDrug

AbbVie Accuses BeiGene of Trade Secret Theft in BTK Degrader Dispute